The Giants of Cancer Care program, presented by OncLive, announced today that 10 new members have joined their Advisory Panel, the judiciary body for the premier awards program. These additions bring the total number of advisory panel members to 29, and highlights the continued growth of the program in 2014.

The Giants of Cancer Care initiative recognizes and celebrates individuals who have achieved landmark success within the field of oncology. The Advisory Panel is an exclusive board of oncologists, educators, clinicians and researchers who have dedicated their valuable time to the program, providing guidance to OncLive as it further develops the program and, most importantly, selects the oncologists who will be named Giants.

The Advisory Panel’s insights are crucial for continued success, and the new members will bring their exemplary experience and tenure to the program. The complete advisory panel list is as follows:

		Hope S. Rugo, MD (Chair) — UCSF Helen Diller Family Comprehensive Cancer Center

		Alex A. Adjei, MD — Roswell Park Cancer Institute

		Johanna Bendell, MD — Sarah Cannon Research Institute, Tennessee Oncology

		Patrick Borgen, MD — Maimonides Medical Center

		Julie R. Brahmer, MD — Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

		Jennifer Brown, MD — Dana Farber Cancer Institute

		Barbara Burtness, MD — Fox Chase Cancer Center, Temple University

		Ezra Cohen, MD — UCSD Moores Cancer Center

		Massimo Cristofanilli, MD — Kimmel Cancer Center, Thomas Jefferson University Hospital

		Cathy Eng, MD — MD Anderson Cancer Center

		Alessandra Ferrajoli, MD — MD Anderson Cancer Center

		Leonard G. Gomella, MD — Kimmel Cancer Center, Thomas Jefferson University Hospital

		Roy Herbst, MD — Yale Comprehensive Cancer Center

		Corey Langer, MD — Abramson Cancer Center, University of Pennsylvania

		Jason Luke, MD — Dana Farber Cancer Institute

		Maurie Markman, MD — Cancer Treatment Centers of America

		Susan O’Brien, MD — MD Anderson Cancer Center

		William Oh, MD — Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute

		Joyce O’Shaughnessy, MD — Baylor Charles A. Sammons Cancer Center, Texas Oncology

		Daniel A. Osman, MD — Chair Emeritus, Miami Breast Cancer Conference

		Roman Perez-Soler, MD — Montefiore Medical Center, Albert Einstein College of Medicine

		Daniel Petrylak, MD — Yale Comprehensive Cancer Center

		Lauren C. Pinter-Brown MD — UCLA Geffen School of Medicine

		Jonathan Strosberg, MD — Moffitt Cancer Center

		Debu Tripathy, MD — USC Norris Comprehensive Cancer Center

		Heather Wakelee, MD — Stanford University School of Medicine

		Jeffrey Weber, MD — Moffitt Cancer Center

		Howard (Jack) West, MD — Swedish Cancer Institute

		Andrew Zelenetz, MD — Memorial Sloan-Kettering Cancer Center

“We are proud to welcome our new Advisory Panel members as they help us fulfill our mission to improve the quality of life for cancer patients,” said OncLive Chairman and CEO Mike Hennessy.

The Advisory Panel is chaired by Hope S. Rugo, MD, a medical oncologist and hematologist specializing in breast cancer research and treatment. Rugo is the Director of the Breast Oncology Clinical Trials Program at the UCSF Helen Diller Family Comprehensive Cancer Center, and is the principal investigator for multiple clinical trials focusing on combining novel targeted therapeutics with standard treatment to improve the treatment of both early and late-stage breast cancer. She is an active member of the national cooperative group, CALGB, and is a founding member of the Breast Cancer Research Consortium, as well as serving as an investigator in the UCSF Breast SPORE (the Bay Area Specialized Program of Research Excellence in Breast Cancer). Rugo also teaches medical students and physicians, and regularly lectures locally, nationally and internationally on subjects relating to the treatment of breast cancer.

To learn more about the Giants of Cancer Care program and view the 2013 class of Giants, visit 

OncLive.com is the official web portal for Intellisphere’s Oncology Specialty Group, which publishes 

OncologyLive, Oncology & Biotech News, Oncology Nursing News, 

The American Journal of Hematology/Oncology,

, and presents the Giants of Cancer Care program. The mission of OncLive

 and its family of publications is to provide oncology professionals with the resources and information they need to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of healthcare publishing, research, and education. To learn more, please visit 

Articles

OncLive brings total of 29 esteemed oncologists to awards panel for insight.

Giants of Cancer Care Awards Program Advisory Panel Grows By Leaps and Bounds

Oncology Luminaries Selected by Peers for Prestigious National Honor

 -- OncLive today announced the 2013 “Giants of Cancer Care,” 12 luminaries selected by oncology industry peers for their remarkable achievements in research and/or clinical practice. The inaugural 

 awards recognize and celebrate individuals who have achieved landmark success within the field of oncology.

The Giants program is presented by OncLive, the official website for 

. Giants are organized by specialty and chosen by an exclusive advisory panel of oncology educators, clinicians and researchers.

OncLive Chairman and CEO Mike Hennessy said, “We’re proud to honor these exemplary members of the oncology profession. These ‘Giants’ have dedicated their lives to improving the quality and quantity of life for cancer patients. Our enormous gratitude is the foundation of this program.”

In evaluating criteria for selection to the inaugural class of Giants, the Advisory Panel considered “pioneers,” characterized by individuals who have amassed a large body of work and have already accomplished their most notable contributions to oncology; and separately, “innovators,” those who recently (within approximately the past 10 years) have made a significant contribution to patient care, clinical trials or translational research.

: Bernard Fisher, M.D., University of Pittsburgh

Pioneer in the biology and treatment of breast cancer

: Bert Vogelstein, M.D., Johns Hopkins Medicine

Pioneer who discovered the molecular basis of colorectal cancer

: Elizabeth H. Blackburn, Ph.D., University of California, San Francisco

Innovator in the genetic composition and function of telomeres

: Lawrence H. Einhorn, M.D., Indiana University

Pioneered a life-saving treatment for testicular cancer

: Everett E. Vokes, M.D., University of Chicago

Innovator of concomitant chemoradiation therapy for head and neck cancers

: Brian J. Druker, M.D., Oregon Health & Sciences University

Innovator of targeted therapies for chronic myeloid leukemia

: Thomas J. Lynch, Jr., M.D., Yale Cancer Center

Pioneered the use of molecular testing for EGFR mutations in lung cancer

: Vincent T. DeVita, Jr., M.D., Yale Cancer Center

Innovator of combination chemotherapy regimens for large-cell lymphomas

: Steven A. Rosenberg, M.D., National Institutes of Health

Pioneered adoptive immunotherapy in melanoma

Pioneer in myeloma research, treatment and education

: Charles L. Sawyers, M.D., Memorial Sloan-Kettering Cancer Center

Innovator of novel androgen-receptor inhibitor for treatment of advanced prostate cancer

: Judah Folkman, M.D., Harvard Medical School (deceased)

The 2013 Giants of Cancer Care will be acknowledged at an invitation-only reception Friday, July 26 at the Hyatt Regency in Huntington Beach, California. Each Giant will be individually profiled in a November 2013 special edition of 

 and prominently featured on OncLive.com.

OncLive today announced the 2013 "Giants of Cancer Care," 12 luminaries selected by oncology industry peers for their remarkable achievements in research and/or clinical practice.

OncLive Announces 2013 "Giants of Cancer Care"

OncLive Gives Partners a Forum for Their Research, Events & Initiatives

 is proud to announce that Emory University’s Nell Hodgson Woodruff School of Nursing has joined its Strategic Alliance Partnership program.

The Strategic Alliance Partnership program enables both parties to benefit from shared knowledge and increased visibility in the oncology community. The school of nursing will be able to showcase its institution, faculty, and programs to a national audience of oncology professionals through OncLive’s publications and websites, including 

. In turn, OncLive will reach even more health care professionals—including future nurses&mdash;with the latest practical information and cutting-edge research through its publications and website

The Nell Hodgson Woodruff School of Nursing is a 108-year-old institution that is ranked among the top 10 private schools of nursing in the country. It graduates more than 200 baccalaureate, master, and doctoral students each year.

 “As one of the top nursing schools in the nation, the Nell Hodgson Woodruff School of Nursing is a wonderful addition to our Strategic Alliance Partnership roster,” said Jack Lepping, president of the oncology division of Intellisphere, the publisher of OncLive

 “We are honored and eager to begin working with the faculty and sharing their work and research with our readers.”

This year, 16 cancer centers and nursing schools have joined OncLive’s Strategic Alliance Partnership program. 

To learn more about OncLive and its Strategic Alliance program, visit 

OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes 

Oncology & Biotech News, OncologyLive, Oncology Nursing News, 

. The mission of OncLive and its family of publications is to provide oncology professionals with the resources and information they need to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of health care publishing, research and education. To learn more, please visit 

OncLive is proud to announce that Emory University's Nell Hodgson Woodruff School of Nursing has joined its Strategic Alliance Partnership program.

Emory University's Nell Hodgson Woodruff School of Nursing Joins OncLive's Strategic Alliance Partnership

 is pleased to announce that the Herbert Irving Comprehensive Cancer Center has joined its Strategic Alliance Partnership program.

This program enables the Herbert Irving Comprehensive Cancer Center to promote its institution and faculty as leaders in oncology to a national audience of oncology professionals through 

OncLive offers a suite of leading oncology publications and websites, and through its reach provides oncology professionals with the latest data and cutting-edge research

 Through the partnership, both parties will benefit from shared knowledge and increased visibility in the oncology community.

The Herbert Irving Comprehensive Cancer Center is Columbia University’s organizational structure for the conduct of cancer research and patient care. It is one of only 41 National Cancer Institute-designated comprehensive cancer centers in the country.

“We are thrilled to have the Herbert Irving Comprehensive Cancer Center on board as a strategic partner,” said Jack Lepping, president of the oncology division of Intellisphere, the publisher of OncLive

 “The Herbert Irving Comprehensive Cancer Center is a national leader in research, and we can’t wait to share more of its faculty’s important work with our readers.”

This year, 15 cancer centers and nursing schools have joined OncLive’s Strategic Alliance Partnership program. 

To learn more the Strategic Alliance program, visit 

OncLive is pleased to announce that the Herbert Irving Comprehensive Cancer Center has joined its Strategic Alliance Partnership program. 

Herbert Irving Comprehensive Cancer Center Joins OncLive's Strategic Alliance Partnership

Dana-Farber Cancer Institute and Seattle Cancer Care Alliance 

’s Strategic Alliance Partnership Program

, a suite of leading oncology publications and websites, is proud to announce that it has added two more renowned cancer centers to its Strategic Alliance Partnership program.

The Strategic Alliance program, which currently has more than a dozen members, enables both parties to benefit from sharing knowledge and increasing their visibility within the oncology community. The alliance will allow the cancer center partners to showcase their research, events and initiatives to a national audience through 

In turn, OncLive will expand its reach, providing oncology professionals with the latest data and cutting-edge research through its publications and website

OncLive’s newest partners are the Dana-Farber Cancer Institute, a National Cancer Institute Comprehensive Cancer Center and principal teaching affiliate of Harvard Medical School; and the Seattle Cancer Care Alliance, which along with the Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, and Seattle Children's Hospital, form the only National Cancer Institute designated Comprehensive Cancer Center in the Northwest.

“We are honored to work alongside these esteemed medical institutions,” said Lyn Beamesderfer, group editorial director for OncLive

“These relationships enable us to share our work with—and learn from&mdash;the brightest minds in the oncology profession.”

Dana-Farber Cancer Institute and Seattle Cancer Care Alliance Join OncLive's Strategic Alliance Partnership Program.

Press Release

Articles

Giants of Cancer Care Awards Program Advisory Panel Grows By Leaps and Bounds

OncLive Announces 2013 "Giants of Cancer Care"

Emory University's Nell Hodgson Woodruff School of Nursing Joins OncLive's Strategic Alliance Partnership

Herbert Irving Comprehensive Cancer Center Joins OncLive's Strategic Alliance Partnership

OncLive Collaborates With Renowned Cancer Centers